Phil DiGiacomo, PhD, joined Qiming US in 2020 upon completion of his doctoral work. While completing his PhD, Phil worked as an associate at ND Capital, where he focused on sourcing and diligence of early-stage life science companies, as well as portfolio support.
Phil holds a PhD in Bioengineering from Stanford University where, as a SPARK Translational Research Fellow and Training in Biomedical Imaging Fellow, his research focused on the discovery and development of novel biomarkers and therapeutic targets for neuroinflammatory diseases.
He holds an MS in Medicine from the Stanford University School of Medicine and a BS with Distinction in Mathematics, Cognitive Science, and Biomedical Engineering from the University of Virginia.